Patient Support Services Contact Us

Intellectual Property

Successfully bringing biosimilars to market presents a unique set of challenges that requires both legal and scientific expertise to manage.

Coherus advances IP strategies that build on its combined scientific and legal expertise to develop and expand proprietary technologies designed to mitigate risk and enable biosimilar innovation.

We invest in discovering technologies to speed development of biosimilars to patients in need.

Coherus team members reviewing documentation